Abstract
Enzyme activities along the kynurenine pathway were assayed in the tissues of New Zealand white rabbits made diabetic with alloxan treatment and hypercholesterolemic with a high-cholosterol diet. Activities are expressed as nmoles of product forming per min per mg of protein and per g of fresh tissue. Liver tryptophan 2,3-dioxygenase (TDO) was present only in holoenzyme form. This activity decreased in diabetic-hyperlipidemic and hyperlipidemic rabbits in comparison with healthy animals. Small intestine indole 2,3-dioxygenase was markedly higher than liver TDO in all rabbit groups, but did not show any significant difference in the values among the three groups. Mitochondrial kynurenine 3-monooxygenase activity was higher in liver than in kidney, but were unchanged with respect to controls. Kynureninase showed similar specific activities in the liver and kidney among groups, whereas the activity per g of fresh tissue was significantly lower in the liver of hyperlipidemic and kidney of diabetic-hyperlipidemic rabbits than in healthy animals. Kynurenine-oxoglutarate transaminase and kynureninase showed lower values in kidney, but not in liver, of diabetic-hyperlipidemic rabbits. However, 3-hydroxyanthranilate 3,4-dioxygenase activity was reduced in both liver and kidney of diabetic-hypercholesterolemic and hyperlipidemic rabbits compared with controls. Instead, aminocarboxymuconate-semialdehyde decarboxylase (picolinic carboxylase) activity was significantly higher in diabetic-hyperlipidemic rabbits in comparison with hyperlypidemic and control rabbits.
Therefore, in diabetic rabbits, there is an alteration of tryptophan metabolism at the level of 3-hydroxyanthranilic acid --* nicotinic acid step, which has the effect of reducing the biosynthesis of NAD in diabetes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A. Bertazzo, E. Ragazzi, M.Biasiolo, C.V.L. Costa, G. Allegri, Enzyme activities involved in tryptophan metabolism along the kynurenine pathway in rabbits, Biochim. Biophys. lcta 1527, 167–175 (2001).
L.M. Henderson, G.B. Ramasarma, B.C. Johnson, Quinolinic acid metabolism IV. Urinary excretion by man and other mammals as affected by the ingestion of tryptophan, J. Biol. Chem. 181, 731–738 (1949).
A.C. Da Silva, R. Fried, R.C. De Angelis, The domestic cat as a laboratory animal for experimental nutrition studies, J. Nuir. 46, 399–409 (1952).
E.G. McDaniel, J.M. Hundley, W.H. Sebrell, Tryptophan-niacin metabolism in alloxan diabetic rats, J. Nutr. 59, 407–423 (1956).
A.H. Mehler, E.G. McDaniel, J.M. Hundley, Changes in the enzymatic composition of liver I. Increase of aminocarboxymuconate-semialdehyde decarboxylase in diabetes, J. Biol. Chem. 232, 323–330 (1958).
J.M. Schor and E. Frieden, Induction of tryptophan peroxidase of rat liver by insulin and alloxan, J. Biol. Chem. 233, 612–618 (1958).
N.B. Ruderman, S. Gupta, I. Sussman, Hyperglycemia, diabetes, and vascular disease: an overview, in: Hyperglycemia, Diabetes, and Vascular Disease, edited by N. Ruderman, J. Williamson, M. Brownlee (Oxford University Press, New York, 1992), pp. 3–20.
J.L. Dixon, J.D. Stoops, J.L. Parker, M.H. Laughlin, G.A. Weisman, M. Sturek, Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet, Arterioscler. Thromb. Vasc. Biol. 19, 2981–2992 (1999).
E. Ragazzi, C.L.V. Costa, L. Caparrotta, M. Biasiolo, A. Bertazzo, G. Allegri, Enzyme activities along the tryptophan-nicotinic acid pathway in alloxan diabetic rabbits. Biochim. Biophys. Acta,1571, 9–17 (2002).
O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265–275 (1951).
A.A-B. Badawy & M. Evans, Animal liver tryptophan pyrrolases. Absence of apoenzyme and of hormonal induction mechanism from species sensitive to tryptophan toxicity, Biochem. J. 158, 79–88 (1976).
E. Ginoulhiac, L.T. Tenconi, U. Bonomi, Attività enzimatiche della linea triptofano-acido nicotinico nel diabete da pancreasectomia del ratto, Acta Vitamin. (Milano) 18, 205–216 (1964).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Allegri, G., Zaccarin, D., Ragazzi, E., Froldi, G., Bertazzo, A., Costa, C.V. (2003). Metabolism of Tryptophan Along the Kynurenine Pathway in Alloxan Diabetic Rabbits. In: Allegri, G., Costa, C.V.L., Ragazzi, E., Steinhart, H., Varesio, L. (eds) Developments in Tryptophan and Serotonin Metabolism. Advances in Experimental Medicine and Biology, vol 527. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0135-0_45
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0135-0_45
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4939-6
Online ISBN: 978-1-4615-0135-0
eBook Packages: Springer Book Archive